CAMP4 Therapeutics Corp
NASDAQ:CAMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CAMP4 Therapeutics Corp
NASDAQ:CAMP
|
US |
|
Trustmark Corp
NASDAQ:TRMK
|
US |
|
R
|
Ryder System Inc
F:RYD
|
US |
|
L
|
Lifestyle Communities Ltd
OTC:LCOMF
|
AU |
|
M
|
MGM Resorts International
F:MGG
|
US |
|
R
|
Relx PLC
XMUN:RDED
|
UK |
|
Sasol Ltd
NYSE:SSL
|
ZA |
|
G
|
Great-West Lifeco Inc
F:GWS
|
CA |
|
S
|
Sansiri PCL
SET:SIRI
|
TH |
Intrinsic Value
Is CAMP undervalued or overvalued?
See the intrinsic value estimate for CAMP4 Therapeutics Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What CAMP4 Therapeutics Does
CAMP4 Therapeutics is a biotechnology company that tries to treat genetic diseases by controlling how much of a gene is turned on or off. Instead of making a traditional drug that blocks a single protein, it looks at the gene regulatory system that tells cells how much of a protein to make. Its work centers on finding medicines that can restore healthier gene activity in diseases where too little or too much of a protein is part of the problem.
- Headquarters
- United States of America US
- Employees
- 48
- IPO date
- Oct 11, 2024
Earnings Waterfall
CAMP4 Therapeutics Corp
The intrinsic value for CAMP4 Therapeutics Corp (CAMP) under the Base Case is hidden USD.
Compared with the current market price of 3.65 USD, the stock appears hidden.